{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:58:28Z","timestamp":1789613908527,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mrijournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.mri.2016.08.018","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T06:01:51Z","timestamp":1472882511000},"page":"1366-1372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gadolinium deposition in the brain: Lessons learned from other metals known to cross the blood\u2013brain barrier"],"prefix":"10.1016","volume":"34","author":[{"given":"John P.","family":"Prybylski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Coste Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mri.2016.08.018_bb0005","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.mri.2016.08.018_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1527-3466.2001.tb00182.x","article-title":"Basic experimental studies and clinical aspects of gadolinium salts and chelates","volume":"19","author":"Adding","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.mri.2016.08.018_bb0015","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.21966","article-title":"Primer on gadolinium chemistry","volume":"30","author":"Sherry","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2016.08.018_bb0020","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jmri.21969","article-title":"Biodistribution of gadolinium-based contrast agents, including gadolinium deposition","volume":"30","author":"Aime","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.mri.2016.08.018_bb0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/RLI.0000000000000228","article-title":"Gadolinium deposition in humans: when did we learn that gadolinium was deposited in vivo?","volume":"51","author":"Huckle","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2016.08.018_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0040","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/ndt\/gfl294","article-title":"Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mri.2016.08.018_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mri.2016.08.018_bb0050","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMcpc0708697","article-title":"Case 6-2008 \u2014 a 46-year-old woman with renal failure and stiffness of the joints and skin","volume":"358","author":"Kay","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mri.2016.08.018_bb0055","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/ndt\/gfr085","article-title":"Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis - an autopsy-based review","volume":"26","author":"Sanyal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mri.2016.08.018_bb0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0730-725X(90)90055-7","article-title":"The relationship between thermodynamics and the toxicity of gadolinium complexes","volume":"8","author":"Cacheris","year":"1990","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.mri.2016.08.018_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/mrm.1910160107","article-title":"Gadolinium ( III ) complex equilibria: the implications for Gd ( III ) MRI contrast agents","volume":"16","author":"Jackson","year":"1990","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.mri.2016.08.018_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2214\/AJR.14.14268","article-title":"Prospective cohort study of nephrogenic systemic fibrosis in patients with stage 3\u20135 chronic kidney disease undergoing MRI with injected Gadobenate dimeglumine or Gadoteridol","volume":"205","author":"Soulez","year":"2015","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.mri.2016.08.018_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.rli.0000112789.57341.01","article-title":"Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy","volume":"39","author":"Gibby","year":"2004","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1039\/b905145g","article-title":"Incorporation of excess gadolinium into human bone from medical contrast agents","volume":"1","author":"Darrah","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.mri.2016.08.018_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tox.2008.03.012","article-title":"Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review","volume":"248","author":"Id\u00e9e","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.mri.2016.08.018_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-4274(99)00272-6","article-title":"Metal\u2013bone interactions","volume":"112","author":"Berglund","year":"2000","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.mri.2016.08.018_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacr.2015.11.009","article-title":"National Institutes of Health perspective on reports of gadolinium deposition in the brain","volume":"13","author":"Malayeri","year":"2016","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2015150805","article-title":"Residual or retained gadolinium: practical implications for radiologists and our patients","volume":"275","author":"Kanal","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2016.08.018_bb0105","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3109\/02841851.2010.515614","article-title":"Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy","volume":"51","author":"Xia","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0110","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1681\/ASN.2005060663","article-title":"Control of hyperphosphatemia among patients with ESRD","volume":"16","author":"Coladonato","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.mri.2016.08.018_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiol.2511081269","article-title":"Multiple sclerosis: Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype","volume":"251","author":"Roccatagliata","year":"2009","journal-title":"RSNA Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1148\/radiol.10100508","article-title":"Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation","volume":"258","author":"Kasahara","year":"2011","journal-title":"RSNA Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0125","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2016.08.018_bb0130","first-page":"1","article-title":"Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation","volume":"00","author":"Errante","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0135","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3174\/ajnr.A4378","article-title":"Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat gadolinium administration","volume":"36","author":"Adin","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0140","doi-asserted-by":"crossref","first-page":"150337","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and Globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2016.08.018_bb0145","doi-asserted-by":"crossref","first-page":"150025","DOI":"10.1148\/radiol.15150025","article-title":"Intracranial gadolinium deposition after contrast-enhanced MR imaging","volume":"275","author":"McDonald","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.mri.2016.08.018_bb0150","first-page":"1","article-title":"Macrocyclic and other non\u2013group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue","volume":"00","author":"Murata","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0969-8051(93)90039-W","article-title":"Dose-dependent biodistribution of [153Gd]Gd(acetate)n in mice","volume":"20","author":"Wedeking","year":"1993","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.mri.2016.08.018_bb0160","article-title":"Comparison of the biodistribution of 153Gd-labeled Gd (DTPA) 2-, Gd (DOTA) -, and Gd (acetate), in mice","volume":"15","author":"Wedeking","year":"1988","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.mri.2016.08.018_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000000241","article-title":"Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats","author":"Robert","year":"2016","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-510X(02)00429-X","article-title":"A brief history of brain iron research","volume":"207","author":"Koeppen","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mri.2016.08.018_bb0175","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI104310","article-title":"The quantitative determination of iron kinetics and hemoglobin synthesis in human subjects","volume":"40","author":"Pollycove","year":"1961","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mri.2016.08.018_bb0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2006-102-309","article-title":"Blood\u2013brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration","volume":"10","author":"Yokel","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mri.2016.08.018_bb0185","first-page":"362","article-title":"The binding and transport of alternative metals by transferrin","volume":"2012","author":"Vincent","year":"1820","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mri.2016.08.018_bb0190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jnr.490270421","article-title":"Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains","volume":"27","author":"Connor","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mri.2016.08.018_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0022-510X(89)90238-4","article-title":"Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients","volume":"94","author":"Morris","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.mri.2016.08.018_bb0200","first-page":"160","article-title":"Structure and function of transferrin","volume":"53","author":"Chung","year":"1989","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.mri.2016.08.018_bb0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0306-4522(03)00590-6","article-title":"Mechanisms and regulation of transferrin and iron transport in a model blood\u2013brain barrier system","volume":"121","author":"Burdo","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.mri.2016.08.018_bb0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4155\/fmc.09.140","article-title":"Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders","volume":"2","author":"Mills","year":"2010","journal-title":"Future Med Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00018-014-1771-4","article-title":"Iron transport across the blood\u2013brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy","volume":"72","author":"McCarthy","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mri.2016.08.018_bb0220","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1208\/s12248-016-9886-1","article-title":"Pharmacodynamic model of hepcidin regulation of iron homeostasis in Cynomolgus monkeys","volume":"18","author":"Krzyzanski","year":"2016","journal-title":"AAPS J"},{"key":"10.1016\/j.mri.2016.08.018_bb0225","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMc070248","article-title":"Nephrogenic systemic fibrosis, gadolinium, and iron mobilization","volume":"357","author":"Swaminathan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mri.2016.08.018_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136563","article-title":"Evidence suggesting a role of iron in a mouse model of nephrogenic systemic fibrosis","volume":"10","author":"Bose","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mri.2016.08.018_bb0235","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0306-4522(82)90019-7","article-title":"The gadolinium ion: a potent blocker of calcium channels and catecholamine release from cultured chromaffin cells","volume":"7","author":"Bourne","year":"1982","journal-title":"Neuroscience"},{"key":"10.1016\/j.mri.2016.08.018_bb0240","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00775-011-0757-z","article-title":"Gadolinium exposure disrupts iron homeostasis in cultured cells","volume":"16","author":"Ghio","year":"2011","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0245","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/3-540-62870-3_3","article-title":"Rationalisation of metal binding to transferrin: prediction of metal-protein stability constants","volume":"88","author":"Sun","year":"1997","journal-title":"Met Sites Proteins Model"},{"key":"10.1016\/j.mri.2016.08.018_bb0250","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/bi00403a033","article-title":"Spectroscopic and thermodynamic studies on the binding of gadolinium (111) to human serum transferrin","volume":"27","author":"Zak","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.mri.2016.08.018_bb0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood.V48.3.449.449","article-title":"Evaluation of iron status of a population","volume":"48","author":"Cook","year":"1976","journal-title":"Blood"},{"key":"10.1016\/j.mri.2016.08.018_bb0260","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1073\/pnas.81.14.4326","article-title":"Occupancy of the iron binding sites of human transferrin","volume":"81","author":"Huebers","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mri.2016.08.018_bb0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cmmi.100","article-title":"Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents","volume":"1","author":"Laurent","year":"2006","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.mri.2016.08.018_bb0270","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1289\/ehp.02110s5699","article-title":"Brain uptake, retention, and efflux of aluminum and manganese","volume":"110","author":"Yokel","year":"2002","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mri.2016.08.018_bb0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1018388803491","article-title":"Uptake of Ga-67 into rat cerebral hemisphere and cerebellum. Comparison with Fe-59","volume":"10","author":"Radunovi\u0107","year":"1997","journal-title":"Biometals"},{"key":"10.1016\/j.mri.2016.08.018_bb0280","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.mri.2016.08.018_bb0285","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1021\/ja803524w","article-title":"The siderocalin \/ enterobactin interaction: a link between mammalian immunity and bacterial iron transport the siderocalin \/ enterobactin interaction:a link between mammalian immunity and bacterial iron transport","volume":"130","author":"Abergel","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mri.2016.08.018_bb0290","doi-asserted-by":"crossref","first-page":"28527","DOI":"10.1039\/C5RA02509E","article-title":"Purification and structural characterization of \u201csimple catechol\u201d, the NGAL-siderocalin siderophore in human urine","volume":"5","author":"Bao","year":"2015","journal-title":"RSC Adv"},{"key":"10.1016\/j.mri.2016.08.018_bb0295","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1074\/jbc.M113.532234","article-title":"The induction of lipocalin-2 protein expression in Vivo and in Vitro","volume":"289","author":"Zhao","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0300","first-page":"1459","article-title":"Cellular and mitochondrial iron homeostasis in vertebrates","volume":"2012","author":"Chen","year":"1823","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mri.2016.08.018_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuint.2015.04.009","article-title":"Expression and localisation of brain-type organic cation transporter (BOCT\/24p3R\/LCN2R) in the normal rat hippocampus and after kainate-induced excitotoxicity","volume":"87","author":"Chia","year":"2015","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mri.2016.08.018_bb0310","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1073\/pnas.1508902112","article-title":"Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides","volume":"112","author":"Allred","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mri.2016.08.018_bb0315","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jps.24394","article-title":"In vitro metabolism and stability of the actinide chelating agent 3,4,3-LI(1,2-HOPO)","volume":"104","author":"Choi","year":"2015","journal-title":"Pharm Assoc J Pharm Sci"},{"key":"10.1016\/j.mri.2016.08.018_bb0320","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nchembio.402","article-title":"Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex","volume":"6","author":"Bao","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.mri.2016.08.018_bb0325","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/jpet.103.049270","article-title":"Sources and significance of plasma levels of catechols and their metabolites in humans","volume":"305","author":"Goldstein","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mri.2016.08.018_bb0330","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/clinchem\/43.12.2408","article-title":"The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum","volume":"43","author":"Gambino","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0335","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0021-9258(19)41699-2","article-title":"The synergistic of anions Fe3+ by transferrin","volume":"250","author":"Schlabach","year":"1975","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0340","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.mri.2016.08.018_bb0345","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00004424-199712000-00009","article-title":"Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging","volume":"32","author":"Cavagna","year":"1997","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0350","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/clinchem\/23.11.2122","article-title":"Albumin\/calcium association at different pH, as determined by potentiometry","volume":"23","author":"Fogh-Andersen","year":"1977","journal-title":"Clin Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0355","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1021\/bi00791a005","article-title":"Gadolinium (3) as a paramagnetic probe for proton relaxation studies of biological macromolecules. Binding to bovine serum albumin","volume":"10","author":"Reuben","year":"1971","journal-title":"Biochemistry"},{"key":"10.1016\/j.mri.2016.08.018_bb0360","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1471-4159.1990.tb04886.x","article-title":"Capillary depletion method for quantification of blood\u2013brain barrier transport of circulating peptides and plasma proteins","volume":"54","author":"Triguero","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2016.08.018_bb0365","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0031-6997(25)06942-X","article-title":"The pharmacology of mechanogated membrane ion channels","volume":"48","author":"Hamill","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mri.2016.08.018_bb0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0960327107070573","article-title":"Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities","volume":"26","author":"Bressler","year":"2007","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.mri.2016.08.018_bb0375","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1085\/jgp.20028740","article-title":"TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions","volume":"121","author":"Monteilh-Zoller","year":"2002","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0380","doi-asserted-by":"crossref","first-page":"30485","DOI":"10.1074\/jbc.M112.364208","article-title":"Substrate profile and metal-ion selectivity of human divalent metal-ion transporter-1","volume":"287","author":"Illing","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mri.2016.08.018_bb0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02820021","article-title":"Uptake of aluminum and gallium into tissues of the rat: influence of antibody against the transferrin receptor","volume":"62","author":"Radunovi\u0107","year":"1998","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.mri.2016.08.018_bb0390","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1471-4159.1992.tb09342.x","article-title":"Dissimilar aluminum and gallium permeation of the blood\u2013brain barrier demonstrated by in vivo microdialysis","volume":"58","author":"Allen","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2016.08.018_bb0395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0006-8993(02)02234-5","article-title":"Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood\u2013brain barrier transport","volume":"930","author":"Yokel","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.mri.2016.08.018_bb0400","unstructured":"NIST Critically Selected Stability Constants of Metal Complexes [Internet]. Version 8.0. Gaithersburg (MD): National Institute of Standards and Technology. c1993 - c2004; 2004 May 1 [cited 2016 May 15]. Available from: http:\/\/www.nist.gov\/srd\/nist46.cfm."},{"key":"10.1016\/j.mri.2016.08.018_bb0405","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.bi.19.070150.002205","article-title":"Chemical composition of blood plasma and serum","volume":"19","author":"Krebs","year":"1950","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.mri.2016.08.018_bb0410","first-page":"159","article-title":"Blood\u2013brain barrier: morphology, physiology, and effects of contrast media","volume":"30","author":"Burns","year":"1981","journal-title":"Adv Neurol"},{"key":"10.1016\/j.mri.2016.08.018_bb0415","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.colsurfb.2008.07.004","article-title":"Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size","volume":"66","author":"Sonavane","year":"2008","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.mri.2016.08.018_bb0420","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4155\/tde.13.38","article-title":"Therapeutic nanomedicine for brain cancer","volume":"4","author":"Tzeng","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1016\/j.mri.2016.08.018_bb0425","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0022-3565(25)23610-2","article-title":"Effect of intravenous ferric or aluminum chloride on the uptake of 203Pb into brain and other soft tissues of rats","volume":"239","author":"Deane","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mri.2016.08.018_bb0430","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mri.2016.08.018_bb0435","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1471-4159.1990.tb02337.x","article-title":"Transport of lead-203 at the blood\u2013brain barrier","volume":"54","author":"Deanne","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.mri.2016.08.018_bb0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13181-013-0343-6","article-title":"The role of chelation in the treatment of other metal poisonings","volume":"9","author":"Smith","year":"2013","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.mri.2016.08.018_bb0445","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/RLI.0b013e3181852171","article-title":"Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C","volume":"43","author":"Frenzel","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.mri.2016.08.018_bb0450","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-016-9916-z","article-title":"Synthesis and physicochemical characterization of a diethyl Ester prodrug of DTPA and its investigation as an oral decorporation agent in rats","author":"Huckle","year":"2016","journal-title":"AAPS J"},{"key":"10.1016\/j.mri.2016.08.018_bb0455","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/ijerph7072745","article-title":"Chelation in metal intoxication","volume":"7","author":"Flora","year":"2010","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.mri.2016.08.018_bb0460","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0022-3565(25)39294-3","article-title":"Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy","volume":"243","author":"Cory-Slechta","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mri.2016.08.018_bb0465","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1021\/es104056m","article-title":"Canadian house dust study: lead bioaccessibility and speciation","volume":"45","author":"Rasmussen","year":"2011","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.mri.2016.08.018_bb0470","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1039\/C5EM00517E","article-title":"Physiologically based modeling of lead kinetics: a pilot study using data from a Canadian population","volume":"17","author":"MacMillan","year":"2015","journal-title":"Environ. Sci. Processes Impacts"},{"key":"10.1016\/j.mri.2016.08.018_bb0475","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/taap.1999.8725","article-title":"The effects of CaNa(2)EDTA on brain lead mobilization in rodents determined using a stable lead isotope tracer","volume":"159","author":"Seaton","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.mri.2016.08.018_bb0480","doi-asserted-by":"crossref","DOI":"10.1097\/RLI.0000000000000266","article-title":"High levels of gadolinium deposition in the skin of a patient with normal renal function","author":"Roberts","year":"2016","journal-title":"Invest Radiol"}],"container-title":["Magnetic Resonance Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X16301230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0730725X16301230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T16:41:40Z","timestamp":1749573700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0730725X16301230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0730725X16301230"],"URL":"https:\/\/doi.org\/10.1016\/j.mri.2016.08.018","relation":{},"ISSN":["0730-725X"],"issn-type":[{"value":"0730-725X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gadolinium deposition in the brain: Lessons learned from other metals known to cross the blood\u2013brain barrier","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mri.2016.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}